Clinical considerations of the role of palbociclib in the management of advanced breast cancer patients with and without visceral metastases

BACKGROUND: This report assesses the efficacy and safety of palbociclib plus endocrine therapy (ET) in women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer (ABC) with or without visceral metastases. PATIENTS AND METHODS: Pre- and postmenopaus...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Oncol
Autors principals: Turner, N C, Finn, R S, Martin, M, Im, S -A, DeMichele, A, Ettl, J, Diéras, V, Moulder, S, Lipatov, O, Colleoni, M, Cristofanilli, M, Lu, D R, Mori, A, Giorgetti, C, Iyer, S, Bartlett, C Huang, Gelmon, K A
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2018
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5888946/
https://ncbi.nlm.nih.gov/pubmed/29342248
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdx797
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars